A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer

Oncogene

Volumn 33, Issue 43, 2014, Pages 5090-5099

  Luis Ravelo, D ^a   Anton I ^a   Zandueta, C ^a   Valencia, K ^a   Ormazabal C ^a   Martinez Canarias S ^a   Guruceaga, E ^b   Perurena, N ^a   Vicent, S ^a,c   De Las Rivas, J ^d   Lecanda, F ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d CSIC   (Spain)

Author keywords

HDAC4; microenvironment; MMP; osteoclastogenesis; outcome; PITX1; ROBO1

Indexed keywords

HISTONE DEACETYLASE; NERVE PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR;

ADENOCARCINOMA; ANIMAL; BONE TUMOR; EXPERIMENTAL NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MOUSE; NUDE MOUSE; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; SECONDARY; SURVIVAL; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NERVE TISSUE PROTEINS; OSTEOCLASTS; OSTEOLYSIS; PAIRED BOX TRANSCRIPTION FACTORS; SURVIVAL ANALYSIS;

EID: 84886107854     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.440     Document Type: Article

References (38)

1. Feld R, Rubinstein LV, Weisenberger TH. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol 1984; 2: 1352-1358.
2. Fry WA, Menck HR, Winchester DP. The National Cancer Data Base report on lung cancer. Cancer 1996; 77: 1947-1955.
3. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG et al. Non-smallcell lung cancer. Lancet 2011; 378: 1727-1740.
4. Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer 2011; 11: 411-425.
5. Coleman RE. Skeletal complications of malignancy. Cancer 1997; 80: 1588-1594.
6. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007; 8: 341-352.
7. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 1996; 98: 1544-1549.
8. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 1999; 103: 197-206.
9. Vicent S, Luis-Ravelo D, Anton I, Garcia-Tunon I, Borras-Cuesta F, Dotor J et al. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Cancer Res 2008; 68: 2275-2285.
10. Valencia K, Ormazabal C, Zandueta C, Luis-Ravelo D, Anton I, Pajares MJ et al. Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis. Clin Cancer Res 2012; 18: 969-980.
11. Antón I, Molina E, Luis-Ravelo D, Zandueta C, Valencia K, Ormazabal C et al. Receptor of activated protein c promotes metastasis and correlates with clinical outcome in lung adenocarcinoma. Am J Resp Crit Care Med 2012; 186: 96-105.
12. Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M et al. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009; 138: 51-62.
13. Catena R, Luis-Ravelo D, Anton I, Zandueta C, Salazar-Colocho P, Larzabal L et al. PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis. Cancer Res 2011; 71: 164-174.
14. Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev 2009; 23: 1882-1894.
15. Luis-Ravelo D, Anton I, Vicent S, Hernandez I, Valencia K, Zandueta C et al. Tumorstromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models. Clin Exp Metastasis 2011; 28: 779-791.
16. Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 2008; 14: 822-827.
17. Yasui T, Kadono Y, Nakamura M, Oshima Y, Matsumoto T, Masuda H et al. Regulation of RANKL-induced osteoclastogenesis by TGF-beta through molecular interaction between Smad3 and Traf6. J Bone Miner Res 2011; 26: 1447-1456.
18. Sapkota G, Knockaert M, Alarcon C, Montalvo E, Brivanlou AH, Massague J. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. J Biol Chem 2006; 281: 40412-40419.
19. Justilien V, Regala RP, Tseng IC, Walsh MP, Batra J, Radisky ES et al. Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential. PLoS One 2012; 7: e35040.
20. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004; 119: 555-566.
21. Backs J, Song K, Bezprozvannaya S, Chang S, Olson EN. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 2006; 116: 1853-1864.
22. Wilson AJ, Byun DS, Nasser S, Murray LB, Ayyanar K, Arango D et al. HDAC4 promotes growth of colon cancer cells via repression of p21. Mol Biol Cell 2008; 19: 4062-4075.
23. Stronach EA, Alfraidi A, Rama N, Datler C, Studd JB, Agarwal R et al. HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer. Cancer Res 2011; 71: 4412-4422.
24. Reddy SD, Pakala SB, Molli PR, Sahni N, Karanam NK, Mudvari P et al. Metastasisassociated protein 1/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function. J Biol Chem 2012; 287: 27843-27850.
25. Marcil A, Dumontier E, Chamberland M, Camper SA, Drouin J. Pitx1 and Pitx2 are required for development of hindlimb buds. Development 2003; 130: 45-55.
26. Kolfschoten IG, van Leeuwen B, Berns K, Mullenders J, Beijersbergen RL, Bernards R et al. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005; 121: 849-858.
27. Lord RV, Brabender J, Wickramasinghe K, DeMeester SR, Holscher A, Schneider PM et al. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. Surgery 2005; 138: 924-931.
28. Chen Y, Knosel T, Ye F, Pacyna-Gengelbach M, Deutschmann N, Petersen I. Decreased PITX1 homeobox gene expression in human lung cancer. Lung Cancer 2007; 55: 287-294.
29. Rhee J, Mahfooz NS, Arregui C, Lilien J, Balsamo J, VanBerkum MF. Activation of the repulsive receptor Roundabout inhibits N-cadherin-mediated cell adhesion. Nat Cell Biol 2002; 4: 798-805.
30. Rhee J, Buchan T, Zukerberg L, Lilien J, Balsamo J. Cables links Robo-bound Abl kinase to N-cadherin-bound beta-catenin to mediate Slit-induced modulation of adhesion and transcription. Nat Cell Biol 2007; 9: 883-892.
31. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436: 518-524.
32. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009; 459: 1005-1009.
33. Yang XM, Han HX, Sui F, Dai YM, Chen M, Geng JG. Slit-Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis. Biochem Biophys Res Commun 2010; 396: 571-577.
34. Labbe E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S et al. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 2007; 67: 75-84.
35. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003; 3: 537-549.
36. Lecanda F. Tumor-stroma: tumor microenvironment as a target to combat metastasis. Dis Model Mech 2011; 8: 87-93.
37. Iguchi H, Onuma E, Sato K, Ogata E. Involvement of parathyroid hormonerelated protein in experimental cachexia induced by a human lung cancerderived cell line established from a bone metastasis specimen. Int J Cancer 2001; 94: 24-27.
38. Hernandez I, Moreno JL, Zandueta C, Montuenga L, Lecanda F. Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer. Oncogene 2010; 29: 3758-3769.